PL2356989T3 - Trwała tabletka zawierająca pochodną 4,5-epoksymorfinanu - Google Patents
Trwała tabletka zawierająca pochodną 4,5-epoksymorfinanuInfo
- Publication number
- PL2356989T3 PL2356989T3 PL09822078T PL09822078T PL2356989T3 PL 2356989 T3 PL2356989 T3 PL 2356989T3 PL 09822078 T PL09822078 T PL 09822078T PL 09822078 T PL09822078 T PL 09822078T PL 2356989 T3 PL2356989 T3 PL 2356989T3
- Authority
- PL
- Poland
- Prior art keywords
- tablet containing
- stable tablet
- epoxymorphinan derivative
- epoxymorphinan
- derivative
- Prior art date
Links
- QONGLMDHKNFCDX-KBHMWOLSSA-N (4r,4ar,12bs)-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinoline Chemical class O1C2CCC[C@H]3[C@]4([H])NCC[C@]23C2=C1C=CC=C2C4 QONGLMDHKNFCDX-KBHMWOLSSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008274579 | 2008-10-24 | ||
| EP09822078.3A EP2356989B1 (en) | 2008-10-24 | 2009-10-23 | Stable tablet containing 4,5-epoxymorphinan derivative |
| PCT/JP2009/068228 WO2010047381A1 (ja) | 2008-10-24 | 2009-10-23 | ４，５－エポキシモルヒナン誘導体を含有する安定な錠剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2356989T3 true PL2356989T3 (pl) | 2018-07-31 |
Family
ID=42119418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09822078T PL2356989T3 (pl) | 2008-10-24 | 2009-10-23 | Trwała tabletka zawierająca pochodną 4,5-epoksymorfinanu |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8829019B2 (pl) |
| EP (1) | EP2356989B1 (pl) |
| JP (2) | JP5648480B2 (pl) |
| KR (1) | KR101682963B1 (pl) |
| CN (1) | CN102196811B (pl) |
| AU (1) | AU2009307367B2 (pl) |
| BR (1) | BRPI0920599B1 (pl) |
| CA (1) | CA2740476C (pl) |
| DK (1) | DK2356989T3 (pl) |
| ES (1) | ES2660001T3 (pl) |
| HU (1) | HUE036876T2 (pl) |
| MX (1) | MX2011004307A (pl) |
| PL (1) | PL2356989T3 (pl) |
| PT (1) | PT2356989T (pl) |
| TR (1) | TR201802379T4 (pl) |
| WO (1) | WO2010047381A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013009505B1 (pt) * | 2010-10-19 | 2022-06-21 | Memorial Sloan-Kettering Cancer Center | Composto, composição farmacêutica, métodos para ensaio quanto a um receptor, e, usos de um composto |
| JP5818219B2 (ja) * | 2012-05-14 | 2015-11-18 | 塩野義製薬株式会社 | ６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤 |
| TWI449704B (zh) * | 2013-04-26 | 2014-08-21 | 臺灣永光化學工業股份有限公司 | 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物 |
| EP4212532A3 (en) | 2015-04-30 | 2023-09-27 | Memorial Sloan Kettering Cancer Center | Mitragynine analogs and uses thereof |
| JP6858575B2 (ja) * | 2016-01-29 | 2021-04-14 | 沢井製薬株式会社 | ナルフラフィン含有口腔内崩壊錠 |
| CN109562109A (zh) * | 2016-07-29 | 2019-04-02 | 东丽株式会社 | 光稳定性提高的固体制剂 |
| EP3603643B1 (en) | 2017-03-31 | 2021-09-15 | Toray Industries, Inc. | Tableted medicinal composition comprising nalfurafine |
| CA3091752A1 (en) | 2018-03-08 | 2019-09-12 | Victoria Link Ltd | Treatment of demyelinating diseases |
| WO2020205735A1 (en) * | 2019-03-29 | 2020-10-08 | Humanwell Pharmaceutical US | Novel morphinans useful for treating medical disorders |
| JP2022130075A (ja) * | 2021-02-25 | 2022-09-06 | フロイント産業株式会社 | 顆粒及びその製造方法、並びに錠剤 |
| MX2023014819A (es) | 2021-06-14 | 2024-03-21 | Scorpion Therapeutics Inc | Derivados de la urea que pueden ser utilizados para tratar el cancer. |
| CN117398353B (zh) * | 2023-12-04 | 2025-04-18 | 山东新时代药业有限公司 | 一种富马酸比索洛尔片剂 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2597475A (en) * | 1949-03-09 | 1952-05-20 | Gilbert & Barker Mfg Co | Separator for removing water from gasoline |
| GB8820327D0 (en) | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
| JP2525552B2 (ja) | 1992-01-23 | 1996-08-21 | 東レ株式会社 | モルヒナン誘導体および医薬用途 |
| PT914818E (pt) | 1996-06-14 | 2005-08-31 | Kyowa Hakko Kogyo Kk | Comprimido de desintegracao rapida por via intraoral |
| WO1998035679A1 (de) | 1997-02-14 | 1998-08-20 | Gödecke Aktiengesellschaft | Stabilisierung von naloxonhydrochlorid |
| EP0915094B1 (en) * | 1997-03-27 | 2007-11-07 | Toray Industries, Inc. | Morphinane derivatives and medicinal use thereof |
| CA2265767C (en) | 1997-07-11 | 2007-12-04 | Nobuyuki Hanamura | Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative |
| US6572891B1 (en) * | 1999-10-23 | 2003-06-03 | Alkaloid Ad | Sublingual oral dosage form |
| JP3595765B2 (ja) * | 2000-09-27 | 2004-12-02 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤 |
| JP4755353B2 (ja) | 2001-04-02 | 2011-08-24 | 興和株式会社 | ビタミンｂ１製剤 |
| AU2003220290B2 (en) | 2002-03-14 | 2007-06-14 | Euro-Celtique S.A. | Naltrexone hydrochloride compositions |
| CN100537573C (zh) * | 2002-10-09 | 2009-09-09 | 东丽株式会社 | 尿频或尿失禁的治疗或预防剂以及具有含氮环状取代基的吗啡烷衍生物 |
| PL2368554T3 (pl) | 2003-04-08 | 2015-05-29 | Progenics Pharm Inc | Preparaty farmaceutyczne zawierające metylonaltrekson |
| TW200507882A (en) * | 2003-07-17 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Solid formulations |
| US20080095841A1 (en) | 2004-10-06 | 2008-04-24 | Eisai R&D Management Co., Ltd. | Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition |
| JP4567640B2 (ja) | 2005-07-29 | 2010-10-20 | 田辺三菱製薬株式会社 | 小型化塩酸サルポグレラート経口投与製剤 |
| TW200806294A (en) * | 2005-11-09 | 2008-02-01 | Toray Industries | Therapeutic or prophylactic agent for functional intestinal injury |
| US8652529B2 (en) * | 2005-11-10 | 2014-02-18 | Flamel Technologies | Anti-misuse microparticulate oral pharmaceutical form |
| JP5204976B2 (ja) | 2006-01-27 | 2013-06-05 | 富山化学工業株式会社 | イグラチモドを含有する速崩壊性錠剤 |
| US20070196494A1 (en) * | 2006-02-17 | 2007-08-23 | Arnaud Grenier | Low-friability, patient-friendly orally disintegrating formulations |
| MX2009001294A (es) * | 2006-08-04 | 2009-05-21 | Ethypharm Sa | Granulo y tableta que se desintegra por vía oral que comprende oxicodona. |
| AU2011294244B2 (en) * | 2010-08-26 | 2014-06-12 | Toray Industries, Inc. | Immunogenic composition |
-
2009
- 2009-10-23 DK DK09822078.3T patent/DK2356989T3/en active
- 2009-10-23 US US13/125,726 patent/US8829019B2/en active Active
- 2009-10-23 WO PCT/JP2009/068228 patent/WO2010047381A1/ja not_active Ceased
- 2009-10-23 MX MX2011004307A patent/MX2011004307A/es unknown
- 2009-10-23 EP EP09822078.3A patent/EP2356989B1/en active Active
- 2009-10-23 PT PT98220783T patent/PT2356989T/pt unknown
- 2009-10-23 ES ES09822078.3T patent/ES2660001T3/es active Active
- 2009-10-23 PL PL09822078T patent/PL2356989T3/pl unknown
- 2009-10-23 BR BRPI0920599-3A patent/BRPI0920599B1/pt active IP Right Grant
- 2009-10-23 KR KR1020117011543A patent/KR101682963B1/ko active Active
- 2009-10-23 AU AU2009307367A patent/AU2009307367B2/en active Active
- 2009-10-23 CA CA2740476A patent/CA2740476C/en active Active
- 2009-10-23 TR TR2018/02379T patent/TR201802379T4/tr unknown
- 2009-10-23 HU HUE09822078A patent/HUE036876T2/hu unknown
- 2009-10-23 JP JP2010534846A patent/JP5648480B2/ja active Active
- 2009-10-23 CN CN200980142056.8A patent/CN102196811B/zh active Active
-
2014
- 2014-03-07 JP JP2014045214A patent/JP5971272B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2356989B1 (en) | 2018-02-07 |
| AU2009307367A1 (en) | 2010-04-29 |
| AU2009307367B2 (en) | 2015-04-23 |
| DK2356989T3 (en) | 2018-05-07 |
| CA2740476A1 (en) | 2010-04-29 |
| US8829019B2 (en) | 2014-09-09 |
| BRPI0920599A2 (pt) | 2020-12-15 |
| KR101682963B1 (ko) | 2016-12-06 |
| EP2356989A4 (en) | 2013-05-08 |
| JP5648480B2 (ja) | 2015-01-07 |
| JPWO2010047381A1 (ja) | 2012-03-22 |
| KR20110074613A (ko) | 2011-06-30 |
| HUE036876T2 (hu) | 2018-08-28 |
| WO2010047381A1 (ja) | 2010-04-29 |
| CN102196811A (zh) | 2011-09-21 |
| JP5971272B2 (ja) | 2016-08-17 |
| CN102196811B (zh) | 2014-03-19 |
| EP2356989A1 (en) | 2011-08-17 |
| JP2014141503A (ja) | 2014-08-07 |
| US20120114752A1 (en) | 2012-05-10 |
| BRPI0920599B1 (pt) | 2021-10-19 |
| ES2660001T3 (es) | 2018-03-20 |
| PT2356989T (pt) | 2018-03-09 |
| TR201802379T4 (tr) | 2018-03-21 |
| CA2740476C (en) | 2016-04-05 |
| MX2011004307A (es) | 2011-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE036876T2 (hu) | 4,5-Epoximorfinán származékot tartalmazó stabil tabletta | |
| IL206765A0 (en) | 4,5-dihydro-oxazol-2-yl-amine derivatives | |
| IL201973A0 (en) | 3,3-spiroindolinone derivatives | |
| ZA201001797B (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
| EP2361902A4 (en) | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG | |
| ZA201104317B (en) | Corn event 5307 | |
| ZA201104706B (en) | Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
| IL225694A0 (en) | Compounds 6,5- dihydro-h1-pyridine-2-one | |
| IL212070A0 (en) | 7-piperidinoalkyl-3,4-dihydroquinolone derivative | |
| IL202830A (en) | Derivatives of indazolamide | |
| GB0710112D0 (en) | Tablet dispenser | |
| AP2010005345A0 (en) | Indazole derivatives. | |
| SI2356123T1 (sl) | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni | |
| IL209423A0 (en) | 4,5-dihydro-oxazol-2-yl derivatives | |
| SI2513119T1 (sl) | 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati | |
| PL394605A1 (pl) | Trwała złożona kompozycja farmaceutyczna | |
| EP2202231A4 (en) | 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE | |
| ZA201005346B (en) | 3,8-diaminotetrahydroquinoline derivative | |
| ZA201103374B (en) | Shelf stable capsules | |
| IL201444A0 (en) | New 4, 8 - diphenyl - polyazanaphthalene derivatives | |
| IL213762A0 (en) | 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| GB0717882D0 (en) | Novel pharmaceutical | |
| IL219623A0 (en) | [1,5]-diazocin derivatives | |
| EP2236135A4 (en) | STABLE PHARMACEUTICAL COMPOSITION | |
| GB0813815D0 (en) | Corcost Pre 1001,10 |